Join to View Full Profile
6202 Harry Hines BlvdSte 1350Dallas, TX 75235
Phone+1 713-798-4508
Dr. Wang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Vanderbilt University Medical CenterFellowship, Hematology and Medical Oncology, 2015 - 2018
Baylor College of MedicineResidency, Internal Medicine, 2012 - 2015- Baylor College of MedicineClass of 2012
Certifications & Licensure
TX State Medical License 2018 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Ad-SGE-DKK3 Gene Therapy Overcomes Resistance to Immune Checkpoint Blockade in Pleural Mesothelioma.Hee-Jin Jang, Meera Patel, Daniel Y Wang, Sung Wook Kang, Jong Min Choi
Clinical Cancer Research. 2025-04-10 - 18 citationsA Phase II Window of Opportunity Study of Neoadjuvant PD-L1 versus PD-L1 plus CTLA-4 Blockade for Patients with Malignant Pleural Mesothelioma.Hyun-Sung Lee, Hee-Jin Jang, Maheshwari Ramineni, Daniel Y Wang, Daniela Ramos
Clinical Cancer Research. 2023-02-01 - 15 citationsPersistent ethnicity-associated disparity in anti-tumor effectiveness of immune checkpoint inhibitors despite equal access.Marcus A Florez, Jan O Kemnade, Nan Chen, Wendy Du, Anita L Sabichi
Cancer Research Communications. 2022-07-26
Journal Articles
- Age Correlates with Response to Anti-PD1, Reflecting Age-Related Differences in Intratumoral Effector and Regulatory T-cell PopulationsZeynep Eroglu, Iman Osman, Theodore S Nowicki, Antoni Ribas, Michael A Davies, Farbod Darvishian, Daniel Y Wang, Douglas B Johnson, Ravi K Amaravadi, Clinical Cancer Research
Press Mentions
Melanoma Survivor Advocates for Regular Skin Cancer ScreeningsMay 20th, 2021
Standardization Arrives for Neoadjuvant Trials in MelanomaAugust 6th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
